Alliance NCORP Research Base
Alliance NCORP Research Base
批准号:
10679045
负责人:
Evanthia Galanis
金额:
$1051.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2025-07-31
关键词:
Academic Medical CentersAddressAdvocateAgingAreaAttentionBehaviorBloodCancer BurdenCancer PatientCancer Research ProjectCaregiversClinicalClinical OncologyClinical ResearchClinical TrialsCollaborationsCollectionCommittee MembershipCommunitiesCommunity Clinical Oncology ProgramCompanionsDataData ReportingDatabasesDevelopmentDiagnosisDiseaseDisparityEarly DiagnosisEducationElderlyFunctional disorderFundingFunding OpportunitiesGrantHealthHumanIncidenceInterventionMaintenanceMalignant NeoplasmsManuscriptsMentorsMentorshipMetastatic Neoplasm to the BoneMetastatic malignant neoplasm to brainMinorityMinority GroupsMissionMonitorMorbidity - disease rateNational Cancer InstituteNational Clinical Trials NetworkNatural HistoryNausea and VomitingOncologistOncologyOutcomeOutcome AssessmentOutcomes ResearchParentsPatient Outcomes AssessmentsPatientsPharmacologic SubstancePopulationPrevalencePreventionPublishingQuality of lifeResearchResearch MethodologyResearch PersonnelResearch PriorityRiskSiteSourceSymptomsTechnologyTissue SampleToxic effectTrainingTranslational ResearchTumor TissueUnderserved PopulationUnited StatesWorkbasecancer carecancer clinical trialcancer health disparitycancer preventioncancer riskcancer therapycare deliverychemotherapyclinically relevantclinically significantcommunity engagementcurative treatmentsdata sharingdisparity eliminationdisparity reductionexperiencefinancial toxicityforginghealth disparityhigh riskimprovedinnovationmortalitymultidisciplinarynext generationnovelolder patientpremalignantpreventprogramsreduce symptomsrepositoryskeletal-related eventssurvivorshiptranslational oncologytreatment trialunderserved community
中文摘要
联盟非营利组织研究基地
英文摘要
Alliance NCORP Research Base
Project Summary/Abstract
The Alliance for Clinical Trials in Oncology (Alliance), one of five National Clinical Trials Network groups,
serves as the parent organization for the Alliance NCI Community Oncology Research Program (NCORP)
Research Base (Alliance NCORP). The Alliance NCORP conducts interventional and observational clinical
and translational research as well as database studies – all of which address important questions relevant to
cancer prevention, symptom control, and cancer care delivery. In addition, the Alliance NCORP conducts
clinically important quality of life studies that are embedded within cancer treatment trials. It places special
emphasis on minority, underserved and older patients at risk for or diagnosed with cancer, and on building
strong collegial relationships with NCORP Community sites and Minority/Underserved Community sites. The
Alliance NCORP committee membership includes rich representation from both community-based and
academic medical centers, as well as patient advocates, thus generating research results relevant to cancer
patients across the United States. The Alliance NCORP also emphasizes mentorship and training of junior
investigators. Over this past grant cycle, i.e., since August 2014, the Alliance NCORP has published 148
manuscripts and abstracts. This work has included practice-changing research in such areas as the
prevention of chemotherapy-induced nausea and vomiting, the prevention of skeletal-related events from
osseous metastases, the management of brain metastases, and the integration of patient-reported outcomes
into cancer clinical trials. The Alliance NCORP conducts translational research that requires the collection of
tumor tissue, premalignant tissue samples, blood, and other human biospecimens; and shares data and
biospecimens for pooled analyses and other scientific collaborations. These biospecimens create an
invaluable repository for understanding clinical observations from a mechanistic standpoint. The Alliance
NCORP also collaborates broadly with other NCI-funded investigators and consortia, as well as with
investigators supported through non-NCI sources. This practice-changing research and the scientific
questions answered by the Alliance NCORP provide meaningful and innovative contributions to clinical and
translational oncology, which can be conducted only within a publicly-funded research network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel multipronged Immunovirotherapy Approach for GBM Treatment
-
批准号:10173067
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2021
-
负责人:Evanthia Galanis
-
依托单位:
Novel multipronged Immunovirotherapy Approach for GBM Treatment
-
批准号:10557886
-
项目类别:
-
资助金额:$45.7万
-
财政年份:2021
-
负责人:Evanthia Galanis
-
依托单位:
Novel multipronged Immunovirotherapy Approach for GBM Treatment
-
批准号:10359174
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2021
-
负责人:Evanthia Galanis
-
依托单位:
Alliance for Clinical Trials in Oncology Operations Center
-
批准号:10593894
-
项目类别:
-
资助金额:$953.4万
-
财政年份:2014
-
负责人:Evanthia Galanis
-
依托单位:
Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas
-
批准号:8403544
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2011
-
负责人:Evanthia Galanis
-
依托单位:
Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas
-
批准号:8594159
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2011
-
负责人:Evanthia Galanis
-
依托单位:
Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas
-
批准号:8208213
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2011
-
负责人:Evanthia Galanis
-
依托单位:
Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas
-
批准号:8018283
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2011
-
负责人:Evanthia Galanis
-
依托单位:
Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer
-
批准号:7727448
-
项目类别:
-
资助金额:$39.87万
-
财政年份:2009
-
负责人:Evanthia Galanis
-
依托单位:
Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer
-
批准号:8061636
-
项目类别:
-
资助金额:$42.42万
-
财政年份:2009
-
负责人:Evanthia Galanis
-
依托单位:
Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer
-
批准号:8249099
-
项目类别:
-
资助金额:$50.71万
-
财政年份:2009
-
负责人:Evanthia Galanis
-
依托单位:
Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer
-
批准号:7727772
-
项目类别:
-
资助金额:$52.95万
-
财政年份:2009
-
负责人:Evanthia Galanis
-
依托单位:
Measles Virotherapy for Glioblastoma Multiforme
-
批准号:7282694
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2006
-
负责人:Evanthia Galanis
-
依托单位:
Measles Virotherapy for Glioblastoma Multiforme
-
批准号:7158695
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2006
-
负责人:Evanthia Galanis
-
依托单位:
Project 3: Measles virus based immunovirotherapy in the treatment of metastatic breast cancer
-
批准号:10017910
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2005
-
负责人:Evanthia Galanis
-
依托单位:
INTRAPERITONEAL ADMINISTRATION OF A STRAIN OF MEASLES VIRUS IN OVARIAN CA
-
批准号:7206166
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2005
-
负责人:Evanthia Galanis
-
依托单位:
Optimizing Measles Virotherapy in the Treatment of Gliomas
-
批准号:8555423
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2004
-
负责人:Evanthia Galanis
-
依托单位:
Targeted MV-CEA as a Potent Antitumor Agent against GBM
-
批准号:6844490
-
项目类别:
-
资助金额:$13.67万
-
财政年份:2004
-
负责人:Evanthia Galanis
-
依托单位:
Measles Virus Therapy for Ovarian Cancer
-
批准号:6691565
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2003
-
负责人:Evanthia Galanis
-
依托单位:
Phase II Trial of CCI-779 in Recurrent Glioblastoma
-
批准号:7042304
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2003
-
负责人:Evanthia Galanis
-
依托单位:
海外基金